References
- SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
- FabbriLMLuppiFBeghéBRabeKFComplex chronic comorbidities of COPDEur Respir J200831120418166598
- García-OlmosLAlberquillaÁAyalaVComorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional studyBMC Fam Pract2013141123324308
- FearyJRRodriguesLCSmithCJHubbardRBGibsonJEPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax2010651195696220871122
- GottliebSSMcCarterRJVogelRAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med199833984894979709041
- ChenJRadfordMJWangYMarciniakTAKrumholzHMEffectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthmaJ Am Coll Cardiol20013771950195611401137
- SmithSCBlairSNBonowROAHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardio-vascular disease: 2001 update a statement for healthcare professionals from the American Heart Association and the American College of CardiologyCirculation20011041577157911571256
- SmithSCAllenJBlairSNAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the national heart, lung, and blood instituteJ Am Coll Cardiol2006472130213916697342
- DoughtyRNRodgersASharpeNMacMahonSEffects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trialsEur Heart J19971845605659129883
- HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- SalpeterSROrmistonTMSalpeterEECardioselective beta-blockers in patients with reactive airway disease: a meta-analysisAnn Intern Med2002137971572512416945
- DransfieldMTRoweSMJohnsonJEBaileyWCGeraldLBUse of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPDThorax200863430130517951276
- AuDHBrysonCLFanVSBeta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary diseaseAm J Med20041171292593115629731
- ShortPMLipworthSIElderDHSchembriSLipworthBJEffect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ2011342d254921558357
- RuttenFHZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med20101701088088720498416
- DuQSunYDingNLuLChenYBeta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studiesPLoS One2014911e11304825427000
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- WangCYLaiCCYangWCThe association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) studyInt J Chron Obstruct Pulmon Dis2016112775278327877031
- MatthewsRBrillISAS® programs to select controls for matched case-control studiesSAS User Group ProceedingsBirmingham, ALUniversity of Alabama at Birmingham200530152230
- NiYShiGWanHUse of cardioselective beta-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trialsJ Int Med Res20124062051206523321161
- SalpeterSOrmistonTSalpeterECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD003566
- MikiATanakaYOhtaniHSawadaYBetaxolol-induced deterioration of asthma and a pharmacodynamic analysis based on beta-receptor occupancyInt J Clin Pharmacol Ther200341835836412940593
- OfnerSSmithTJBetaxolol in chronic obstructive pulmonary diseaseJ Ocul Pharmacol1987321711762903205
- AnavekarSNBarterCAdamWRDoyleAEA double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways diseaseJ Cardiovasc Pharmacol19824suppl 3S374S3776184571
- van der WoudeHJZaagsmaJPostmaDSWinterTHvan HulstMAalbersRDetrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockersChest2005127381882415764762